Lipoprotein-Associated Phospholipase A 2 and Incident Peripheral Arterial Disease in Older Adults
Author(s) -
Parveen K. Garg,
Alice M. Arnold,
Karen Hinckley Stukovsky,
Carol E. Koro,
Nancy S. Jenny,
Kenneth J. Mukamal,
Michael H. Criqui,
Curt D. Furberg,
Anne B. Newman,
Mary Cushman
Publication year - 2016
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.115.306647
Subject(s) - medicine , hazard ratio , confidence interval , odds ratio , lipoprotein associated phospholipase a2 , claudication , body mass index , prospective cohort study , population , cardiology , arterial disease , vascular disease , cholesterol , lipoprotein , environmental health
Although prior studies report a relationship between elevated lipoprotein-associated phospholipase A2 (Lp-PLA2) and incident cardiovascular disease, the prospective association of Lp-PLA2 with incident peripheral arterial disease (PAD) has not been studied. We investigated the association between Lp-PLA2 mass and activity and the risk of developing clinical PAD and low ankle-brachial index (ABI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom